

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.35589077 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.35407438 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.73112442 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.67986127 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.65227377 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.58083541 |
| 7 | glutamate secretion (GO:0014047) | 5.55928182 |
| 8 | vocalization behavior (GO:0071625) | 5.35865001 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.30307470 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.09060441 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.99636552 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.77549597 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.71414767 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 4.70435976 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.70120314 |
| 16 | protein localization to synapse (GO:0035418) | 4.68448455 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.64714896 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.56975293 |
| 19 | exploration behavior (GO:0035640) | 4.51297532 |
| 20 | potassium ion homeostasis (GO:0055075) | 4.46931286 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.40691266 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.37915669 |
| 23 | axon ensheathment in central nervous system (GO:0032291) | 4.24938735 |
| 24 | central nervous system myelination (GO:0022010) | 4.24938735 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 4.19586297 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.16963948 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 4.16736656 |
| 28 | cellular sodium ion homeostasis (GO:0006883) | 4.08711936 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 4.07885321 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.07575768 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 4.06331468 |
| 32 | amino acid import (GO:0043090) | 4.05944823 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.02515577 |
| 34 | potassium ion import (GO:0010107) | 4.02298834 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.99792432 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.98790713 |
| 37 | proline transport (GO:0015824) | 3.94160107 |
| 38 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.92632161 |
| 39 | neurotransmitter transport (GO:0006836) | 3.88885337 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.85998733 |
| 41 | long-term memory (GO:0007616) | 3.85408733 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.81433561 |
| 43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.76298364 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75012337 |
| 45 | activation of protein kinase A activity (GO:0034199) | 3.65670363 |
| 46 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.63284871 |
| 47 | sodium ion export (GO:0071436) | 3.61117718 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60184861 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 3.56335084 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.56248139 |
| 51 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.55690164 |
| 52 | neuron recognition (GO:0008038) | 3.55663900 |
| 53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54087298 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.53934613 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.53237213 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.52900744 |
| 57 | neuromuscular process controlling posture (GO:0050884) | 3.51848806 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.51302450 |
| 59 | regulation of synapse maturation (GO:0090128) | 3.49594507 |
| 60 | positive regulation of dendritic spine development (GO:0060999) | 3.45365867 |
| 61 | neuromuscular process controlling balance (GO:0050885) | 3.41627395 |
| 62 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.41260981 |
| 63 | neurotransmitter uptake (GO:0001504) | 3.41165629 |
| 64 | long-term synaptic potentiation (GO:0060291) | 3.39015876 |
| 65 | detection of calcium ion (GO:0005513) | 3.37301578 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.36730949 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.33249914 |
| 68 | regulation of vesicle fusion (GO:0031338) | 3.32642092 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32384470 |
| 70 | cell communication involved in cardiac conduction (GO:0086065) | 3.31565724 |
| 71 | auditory behavior (GO:0031223) | 3.31003317 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30977911 |
| 73 | vesicle transport along microtubule (GO:0047496) | 3.27869071 |
| 74 | axonal fasciculation (GO:0007413) | 3.27838650 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.27729894 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.27366394 |
| 77 | postsynaptic membrane organization (GO:0001941) | 3.26863179 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.26613572 |
| 79 | glycine transport (GO:0015816) | 3.26557144 |
| 80 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.25928948 |
| 81 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.22635291 |
| 82 | cell differentiation in hindbrain (GO:0021533) | 3.19184452 |
| 83 | dendrite morphogenesis (GO:0048813) | 3.19160041 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.17691313 |
| 85 | response to auditory stimulus (GO:0010996) | 3.17409295 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.16929641 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.16118543 |
| 88 | presynaptic membrane organization (GO:0097090) | 3.14987424 |
| 89 | membrane depolarization (GO:0051899) | 3.14955710 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.14334515 |
| 91 | synaptic vesicle transport (GO:0048489) | 3.13527188 |
| 92 | establishment of synaptic vesicle localization (GO:0097480) | 3.13527188 |
| 93 | establishment of mitochondrion localization (GO:0051654) | 3.12956635 |
| 94 | membrane depolarization during action potential (GO:0086010) | 3.12489526 |
| 95 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11639905 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11299179 |
| 97 | acidic amino acid transport (GO:0015800) | 3.10786325 |
| 98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08207610 |
| 99 | L-amino acid import (GO:0043092) | 3.06743758 |
| 100 | adult walking behavior (GO:0007628) | 3.04815424 |
| 101 | neuronal ion channel clustering (GO:0045161) | 3.04758166 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04705685 |
| 103 | response to histamine (GO:0034776) | 3.04132749 |
| 104 | cerebellar granule cell differentiation (GO:0021707) | 3.03781981 |
| 105 | startle response (GO:0001964) | 3.03001741 |
| 106 | regulation of dendritic spine development (GO:0060998) | 3.02851722 |
| 107 | innervation (GO:0060384) | 3.02478233 |
| 108 | prepulse inhibition (GO:0060134) | 3.02442883 |
| 109 | synapse assembly (GO:0007416) | 3.02032382 |
| 110 | organelle transport along microtubule (GO:0072384) | 3.02022166 |
| 111 | learning (GO:0007612) | 3.01419303 |
| 112 | synaptic transmission (GO:0007268) | 3.01370633 |
| 113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00895294 |
| 114 | cell communication by electrical coupling (GO:0010644) | 3.00864821 |
| 115 | regulation of synaptic transmission (GO:0050804) | 2.99633629 |
| 116 | positive regulation of synaptic transmission (GO:0050806) | 2.99340659 |
| 117 | neuromuscular process (GO:0050905) | 2.97336562 |
| 118 | mating behavior (GO:0007617) | 2.96498025 |
| 119 | neuromuscular synaptic transmission (GO:0007274) | 2.95304661 |
| 120 | cerebellar Purkinje cell layer development (GO:0021680) | 2.94773890 |
| 121 | regulation of ARF protein signal transduction (GO:0032012) | 2.94381405 |
| 122 | social behavior (GO:0035176) | 2.93581330 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.93581330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.10153074 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.62057376 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11968605 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04750341 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02862160 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.87782771 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67696183 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67696183 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.67615230 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.60974133 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57115942 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53538761 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53249856 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52310591 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45335105 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41421683 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40251923 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37696906 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24840966 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21918857 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14867994 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14036287 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09190983 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07795416 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07000114 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.05789951 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01720156 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90556802 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85184381 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.84615840 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80695539 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80518839 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68426228 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65867415 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64191244 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55508131 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55202235 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42685528 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38251187 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37111399 |
| 41 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36100415 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34698599 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34446170 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33355488 |
| 45 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32691853 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29270410 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27824000 |
| 48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27194563 |
| 49 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24865325 |
| 50 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24144306 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23425577 |
| 52 | AR_19668381_ChIP-Seq_PC3_Human | 1.22373705 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.20789466 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18398737 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17710697 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16514913 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16440079 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16165458 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13819619 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13336868 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12205945 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11742595 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11607979 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11484613 |
| 65 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.10348607 |
| 66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10151318 |
| 67 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.09679288 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07982606 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07317648 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05846180 |
| 71 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05643829 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03921617 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03844820 |
| 74 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03684415 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03647945 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03096523 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01648520 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01619638 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00890241 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00613334 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00604920 |
| 82 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.00470954 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99833846 |
| 84 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99264599 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98696967 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98394259 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97948714 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97489546 |
| 89 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.96541116 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95034991 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94837541 |
| 92 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94591255 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93957138 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92910604 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92367807 |
| 96 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92110891 |
| 97 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91788631 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 0.91389106 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90479914 |
| 100 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90211226 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89884505 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89810553 |
| 103 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88419090 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87512480 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86556087 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85958308 |
| 107 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85819999 |
| 108 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85565998 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85219467 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85110713 |
| 111 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84546116 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84282934 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83462492 |
| 114 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81040123 |
| 115 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79852037 |
| 116 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79378316 |
| 117 | * JUN_21703547_ChIP-Seq_K562_Human | 0.77792756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.43531031 |
| 2 | MP0003880_abnormal_central_pattern | 4.89790098 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.16781202 |
| 4 | MP0004270_analgesia | 3.93644066 |
| 5 | MP0009745_abnormal_behavioral_response | 3.41179794 |
| 6 | MP0002064_seizures | 3.28231082 |
| 7 | MP0009046_muscle_twitch | 3.28118573 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.26508115 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.07725324 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.95853073 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.80195024 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.78135540 |
| 13 | MP0002272_abnormal_nervous_system | 2.74881440 |
| 14 | MP0001486_abnormal_startle_reflex | 2.60986780 |
| 15 | MP0002822_catalepsy | 2.30333787 |
| 16 | MP0002736_abnormal_nociception_after | 2.28858819 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.26271889 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.25064160 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.10060956 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.09823928 |
| 21 | MP0001970_abnormal_pain_threshold | 2.03977110 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.03175930 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.00691696 |
| 24 | MP0008569_lethality_at_weaning | 1.99643602 |
| 25 | MP0003329_amyloid_beta_deposits | 1.89706027 |
| 26 | MP0004147_increased_porphyrin_level | 1.85099497 |
| 27 | MP0002184_abnormal_innervation | 1.80491318 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.80130111 |
| 29 | MP0004924_abnormal_behavior | 1.80130111 |
| 30 | MP0000778_abnormal_nervous_system | 1.77458667 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.76307509 |
| 32 | * MP0004811_abnormal_neuron_physiology | 1.75748609 |
| 33 | MP0006276_abnormal_autonomic_nervous | 1.74688611 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.72795674 |
| 35 | MP0004885_abnormal_endolymph | 1.68593805 |
| 36 | MP0004858_abnormal_nervous_system | 1.68017859 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.65242033 |
| 38 | MP0000955_abnormal_spinal_cord | 1.62136398 |
| 39 | MP0003879_abnormal_hair_cell | 1.56388163 |
| 40 | MP0001984_abnormal_olfaction | 1.53123251 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.51756418 |
| 42 | MP0003787_abnormal_imprinting | 1.48614235 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.47499603 |
| 44 | * MP0002882_abnormal_neuron_morphology | 1.47429990 |
| 45 | MP0001905_abnormal_dopamine_level | 1.44009041 |
| 46 | MP0003633_abnormal_nervous_system | 1.42880637 |
| 47 | MP0004142_abnormal_muscle_tone | 1.42635883 |
| 48 | MP0001529_abnormal_vocalization | 1.35540028 |
| 49 | MP0003122_maternal_imprinting | 1.30511303 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.27405275 |
| 51 | MP0003631_nervous_system_phenotype | 1.21175625 |
| 52 | MP0003123_paternal_imprinting | 1.20855924 |
| 53 | MP0002229_neurodegeneration | 1.19191202 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.16679788 |
| 55 | MP0001188_hyperpigmentation | 1.13807126 |
| 56 | MP0000920_abnormal_myelination | 1.11430984 |
| 57 | MP0002152_abnormal_brain_morphology | 1.10560702 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.09084182 |
| 59 | MP0008872_abnormal_physiological_respon | 1.05579910 |
| 60 | MP0004742_abnormal_vestibular_system | 1.04197410 |
| 61 | MP0003634_abnormal_glial_cell | 0.99227652 |
| 62 | MP0003690_abnormal_glial_cell | 0.97396114 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 0.93859543 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 0.90760624 |
| 65 | MP0003632_abnormal_nervous_system | 0.90084013 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.89601419 |
| 67 | MP0008874_decreased_physiological_sensi | 0.89130615 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.87444349 |
| 69 | MP0003283_abnormal_digestive_organ | 0.86097758 |
| 70 | MP0000751_myopathy | 0.86037978 |
| 71 | MP0001177_atelectasis | 0.84815117 |
| 72 | MP0005535_abnormal_body_temperature | 0.83925092 |
| 73 | MP0005394_taste/olfaction_phenotype | 0.83078192 |
| 74 | MP0005499_abnormal_olfactory_system | 0.83078192 |
| 75 | MP0002752_abnormal_somatic_nervous | 0.82270837 |
| 76 | MP0008877_abnormal_DNA_methylation | 0.82042334 |
| 77 | MP0010386_abnormal_urinary_bladder | 0.80613721 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.80457994 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.78520629 |
| 80 | MP0004043_abnormal_pH_regulation | 0.78350951 |
| 81 | MP0005409_darkened_coat_color | 0.78267384 |
| 82 | MP0000604_amyloidosis | 0.76652295 |
| 83 | MP0004085_abnormal_heartbeat | 0.75529489 |
| 84 | MP0003075_altered_response_to | 0.75111164 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.73261874 |
| 86 | MP0002090_abnormal_vision | 0.72507829 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.71323434 |
| 88 | MP0003121_genomic_imprinting | 0.69002246 |
| 89 | MP0006072_abnormal_retinal_apoptosis | 0.63499120 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.61628106 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.61025540 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.60853684 |
| 93 | MP0001664_abnormal_digestion | 0.60418614 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.60291831 |
| 95 | * MP0010768_mortality/aging | 0.60283239 |
| 96 | * MP0010770_preweaning_lethality | 0.59643815 |
| 97 | * MP0002082_postnatal_lethality | 0.59643815 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.58710504 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.58162834 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.58090225 |
| 101 | MP0004233_abnormal_muscle_weight | 0.57723751 |
| 102 | MP0001346_abnormal_lacrimal_gland | 0.57145957 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.56598174 |
| 104 | MP0005187_abnormal_penis_morphology | 0.56360084 |
| 105 | MP0002837_dystrophic_cardiac_calcinosis | 0.56327730 |
| 106 | MP0001943_abnormal_respiration | 0.56295899 |
| 107 | MP0000579_abnormal_nail_morphology | 0.54483196 |
| 108 | * MP0010769_abnormal_survival | 0.53484098 |
| 109 | MP0005253_abnormal_eye_physiology | 0.53240224 |
| 110 | * MP0003956_abnormal_body_size | 0.52926109 |
| 111 | MP0003861_abnormal_nervous_system | 0.52546917 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.52513030 |
| 113 | MP0004484_altered_response_of | 0.51985710 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.51569494 |
| 115 | MP0001731_abnormal_postnatal_growth | 0.41565595 |
| 116 | MP0002873_normal_phenotype | 0.40583866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.46726286 |
| 2 | Myokymia (HP:0002411) | 6.82337740 |
| 3 | Focal seizures (HP:0007359) | 5.69192973 |
| 4 | Visual hallucinations (HP:0002367) | 5.49752651 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.77322461 |
| 6 | Atonic seizures (HP:0010819) | 4.70237799 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.44561989 |
| 8 | Febrile seizures (HP:0002373) | 4.32831545 |
| 9 | Absence seizures (HP:0002121) | 4.25036096 |
| 10 | Action tremor (HP:0002345) | 4.11112107 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.94251979 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.89948681 |
| 13 | Dialeptic seizures (HP:0011146) | 3.89689755 |
| 14 | Ankle clonus (HP:0011448) | 3.84717265 |
| 15 | Broad-based gait (HP:0002136) | 3.54223393 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.45956233 |
| 17 | Poor eye contact (HP:0000817) | 3.31812536 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.30085672 |
| 19 | Depression (HP:0000716) | 3.29726525 |
| 20 | Papilledema (HP:0001085) | 3.29599765 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.29495084 |
| 22 | Dysmetria (HP:0001310) | 3.26253212 |
| 23 | Truncal ataxia (HP:0002078) | 3.22067147 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.19989759 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.15848817 |
| 26 | Mutism (HP:0002300) | 3.14961342 |
| 27 | Abnormal eating behavior (HP:0100738) | 3.06610104 |
| 28 | Anxiety (HP:0000739) | 3.04103102 |
| 29 | Hyperventilation (HP:0002883) | 3.01558617 |
| 30 | Impaired social interactions (HP:0000735) | 3.00201776 |
| 31 | Abnormal social behavior (HP:0012433) | 3.00201776 |
| 32 | Scanning speech (HP:0002168) | 2.97574953 |
| 33 | Spastic gait (HP:0002064) | 2.95110460 |
| 34 | Tetraplegia (HP:0002445) | 2.89241497 |
| 35 | Urinary urgency (HP:0000012) | 2.85957452 |
| 36 | Abnormality of the corticospinal tract (HP:0002492) | 2.83427968 |
| 37 | Intention tremor (HP:0002080) | 2.82869778 |
| 38 | Progressive inability to walk (HP:0002505) | 2.82090084 |
| 39 | Neurofibrillary tangles (HP:0002185) | 2.80766429 |
| 40 | Obstructive sleep apnea (HP:0002870) | 2.80584745 |
| 41 | Pheochromocytoma (HP:0002666) | 2.77640526 |
| 42 | Genetic anticipation (HP:0003743) | 2.76147038 |
| 43 | Impaired smooth pursuit (HP:0007772) | 2.76057275 |
| 44 | Amblyopia (HP:0000646) | 2.68035593 |
| 45 | Excessive salivation (HP:0003781) | 2.67788732 |
| 46 | Drooling (HP:0002307) | 2.67788732 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.67683593 |
| 48 | Limb dystonia (HP:0002451) | 2.63379663 |
| 49 | Termporal pattern (HP:0011008) | 2.58119449 |
| 50 | Insidious onset (HP:0003587) | 2.58119449 |
| 51 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.54207501 |
| 52 | * Postural instability (HP:0002172) | 2.54101283 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.54031380 |
| 54 | Abnormality of binocular vision (HP:0011514) | 2.53519425 |
| 55 | Diplopia (HP:0000651) | 2.53519425 |
| 56 | Torticollis (HP:0000473) | 2.53455253 |
| 57 | Hemiparesis (HP:0001269) | 2.53374091 |
| 58 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.42715416 |
| 59 | Hemiplegia (HP:0002301) | 2.41774621 |
| 60 | Epileptiform EEG discharges (HP:0011182) | 2.40136830 |
| 61 | Neuroendocrine neoplasm (HP:0100634) | 2.36486537 |
| 62 | Lower limb muscle weakness (HP:0007340) | 2.36484987 |
| 63 | Focal dystonia (HP:0004373) | 2.36244066 |
| 64 | Absent speech (HP:0001344) | 2.34600926 |
| 65 | Megalencephaly (HP:0001355) | 2.32963542 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.32815241 |
| 67 | Sleep apnea (HP:0010535) | 2.32718977 |
| 68 | Dysmetric saccades (HP:0000641) | 2.27546473 |
| 69 | Spastic tetraparesis (HP:0001285) | 2.27481647 |
| 70 | Stereotypic behavior (HP:0000733) | 2.26267106 |
| 71 | Fetal akinesia sequence (HP:0001989) | 2.25587403 |
| 72 | * Bradykinesia (HP:0002067) | 2.24656768 |
| 73 | Agitation (HP:0000713) | 2.24199777 |
| 74 | Ventricular fibrillation (HP:0001663) | 2.24058196 |
| 75 | Choreoathetosis (HP:0001266) | 2.23437367 |
| 76 | Impaired vibratory sensation (HP:0002495) | 2.21998401 |
| 77 | Apathy (HP:0000741) | 2.21663067 |
| 78 | Hypsarrhythmia (HP:0002521) | 2.21062237 |
| 79 | Increased circulating renin level (HP:0000848) | 2.17576442 |
| 80 | Generalized myoclonic seizures (HP:0002123) | 2.17507389 |
| 81 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15946595 |
| 82 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15946595 |
| 83 | Polyphagia (HP:0002591) | 2.15781818 |
| 84 | Inability to walk (HP:0002540) | 2.15536615 |
| 85 | Clonus (HP:0002169) | 2.11786425 |
| 86 | Craniofacial dystonia (HP:0012179) | 2.11090679 |
| 87 | Status epilepticus (HP:0002133) | 2.10440714 |
| 88 | CNS hypomyelination (HP:0003429) | 2.10288264 |
| 89 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07083021 |
| 90 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.05590538 |
| 91 | Peripheral hypomyelination (HP:0007182) | 2.01360380 |
| 92 | Blue irides (HP:0000635) | 2.00730299 |
| 93 | Gait ataxia (HP:0002066) | 1.98916187 |
| 94 | Diminished motivation (HP:0000745) | 1.98399286 |
| 95 | Akinesia (HP:0002304) | 1.96898239 |
| 96 | Insomnia (HP:0100785) | 1.94311951 |
| 97 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93298409 |
| 98 | Psychosis (HP:0000709) | 1.93054559 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 1.91958654 |
| 100 | Paraplegia (HP:0010550) | 1.91536700 |
| 101 | Bundle branch block (HP:0011710) | 1.87577720 |
| 102 | Specific learning disability (HP:0001328) | 1.86428377 |
| 103 | Incomplete penetrance (HP:0003829) | 1.85736448 |
| 104 | Spastic paraplegia (HP:0001258) | 1.85281171 |
| 105 | Delusions (HP:0000746) | 1.84985410 |
| 106 | Diminished movement (HP:0002374) | 1.83901076 |
| 107 | Annular pancreas (HP:0001734) | 1.83588067 |
| 108 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.81182131 |
| 109 | Inappropriate behavior (HP:0000719) | 1.80979296 |
| 110 | Abnormality of salivation (HP:0100755) | 1.80320066 |
| 111 | Failure to thrive in infancy (HP:0001531) | 1.80305418 |
| 112 | Spastic tetraplegia (HP:0002510) | 1.79992837 |
| 113 | Gait imbalance (HP:0002141) | 1.79241505 |
| 114 | Aplasia of the phalanges of the hand (HP:0009802) | 1.78481379 |
| 115 | Aplasia involving bones of the extremities (HP:0009825) | 1.78481379 |
| 116 | Pointed chin (HP:0000307) | 1.76029585 |
| 117 | * Rigidity (HP:0002063) | 1.73962952 |
| 118 | Resting tremor (HP:0002322) | 1.73899085 |
| 119 | Postural tremor (HP:0002174) | 1.73665132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.31078916 |
| 2 | MAP3K9 | 3.93144306 |
| 3 | EPHA4 | 3.65592058 |
| 4 | MARK1 | 3.26820285 |
| 5 | MAP3K4 | 3.05240953 |
| 6 | MINK1 | 2.74466802 |
| 7 | MAP2K7 | 2.59673660 |
| 8 | DAPK2 | 2.41377673 |
| 9 | PAK6 | 2.33161297 |
| 10 | MAP3K12 | 2.23853059 |
| 11 | NTRK2 | 2.16010680 |
| 12 | KSR2 | 2.05816024 |
| 13 | NTRK1 | 2.03124192 |
| 14 | MAP2K4 | 1.94275680 |
| 15 | CDK19 | 1.90117406 |
| 16 | PRKD3 | 1.87689076 |
| 17 | CASK | 1.86938055 |
| 18 | CAMKK1 | 1.86344242 |
| 19 | PNCK | 1.60525822 |
| 20 | CDK5 | 1.59900617 |
| 21 | TNIK | 1.54208918 |
| 22 | RIPK4 | 1.53975192 |
| 23 | DAPK1 | 1.45420453 |
| 24 | GRK5 | 1.44765428 |
| 25 | KSR1 | 1.44741422 |
| 26 | PRPF4B | 1.40746552 |
| 27 | CAMKK2 | 1.37199482 |
| 28 | PLK2 | 1.35980192 |
| 29 | UHMK1 | 1.35761255 |
| 30 | MAPK13 | 1.30203475 |
| 31 | ARAF | 1.29806563 |
| 32 | OXSR1 | 1.27355517 |
| 33 | STK38 | 1.22496473 |
| 34 | PRKCG | 1.21081405 |
| 35 | MAP3K2 | 1.18932570 |
| 36 | MAP3K13 | 1.12886618 |
| 37 | RIPK1 | 1.08996249 |
| 38 | TYRO3 | 1.07380766 |
| 39 | FES | 1.04593631 |
| 40 | PHKG2 | 1.02323882 |
| 41 | PHKG1 | 1.02323882 |
| 42 | SIK2 | 1.02109760 |
| 43 | SGK494 | 0.99947374 |
| 44 | SGK223 | 0.99947374 |
| 45 | CAMK2A | 0.99190073 |
| 46 | CDK18 | 0.99001566 |
| 47 | CDK15 | 0.98154917 |
| 48 | CDK14 | 0.96331254 |
| 49 | STK11 | 0.93764922 |
| 50 | CAMK1 | 0.91551791 |
| 51 | CSNK1G2 | 0.88200364 |
| 52 | PRKCH | 0.87772180 |
| 53 | CAMK2B | 0.86930419 |
| 54 | RET | 0.86899367 |
| 55 | CDK11A | 0.85724142 |
| 56 | LATS2 | 0.84604825 |
| 57 | PINK1 | 0.82861973 |
| 58 | PAK3 | 0.80651946 |
| 59 | ALK | 0.80411394 |
| 60 | TAOK1 | 0.79735786 |
| 61 | WNK1 | 0.73828294 |
| 62 | MAPK12 | 0.72113135 |
| 63 | RAF1 | 0.71206094 |
| 64 | STK39 | 0.70555835 |
| 65 | PDK1 | 0.68970478 |
| 66 | SGK2 | 0.67551994 |
| 67 | LMTK2 | 0.66260803 |
| 68 | MARK2 | 0.65138890 |
| 69 | MAPKAPK5 | 0.64468985 |
| 70 | SGK1 | 0.63280026 |
| 71 | PDPK1 | 0.63085952 |
| 72 | NEK6 | 0.61939422 |
| 73 | DYRK1A | 0.61611749 |
| 74 | SGK3 | 0.61179449 |
| 75 | SCYL2 | 0.60342854 |
| 76 | MAP3K1 | 0.60060019 |
| 77 | WNK3 | 0.58309075 |
| 78 | TNK2 | 0.57886421 |
| 79 | CAMK1G | 0.56376862 |
| 80 | BRAF | 0.56373286 |
| 81 | CAMK2D | 0.55511300 |
| 82 | CAMK2G | 0.53427086 |
| 83 | BMPR2 | 0.53019727 |
| 84 | PTK2B | 0.52263886 |
| 85 | RPS6KA3 | 0.48992225 |
| 86 | PRKCZ | 0.46753985 |
| 87 | PRKCE | 0.46714853 |
| 88 | CCNB1 | 0.46179020 |
| 89 | MAPK10 | 0.45908452 |
| 90 | FYN | 0.44982359 |
| 91 | CDC42BPA | 0.44829907 |
| 92 | NEK1 | 0.43034770 |
| 93 | FGFR2 | 0.41181235 |
| 94 | WNK4 | 0.41054624 |
| 95 | CAMK4 | 0.40987640 |
| 96 | CSNK1G3 | 0.40013241 |
| 97 | BCR | 0.39423442 |
| 98 | MAP3K11 | 0.38737392 |
| 99 | ROCK2 | 0.38155982 |
| 100 | MAP3K7 | 0.37800081 |
| 101 | FGR | 0.36660633 |
| 102 | BRSK1 | 0.36396536 |
| 103 | DAPK3 | 0.35805659 |
| 104 | FER | 0.34375444 |
| 105 | AKT3 | 0.34337439 |
| 106 | PKN1 | 0.34151537 |
| 107 | CSNK1E | 0.32616470 |
| 108 | PRKCA | 0.31542403 |
| 109 | PRKCB | 0.31436531 |
| 110 | CSNK1D | 0.30552702 |
| 111 | PRKG1 | 0.29217175 |
| 112 | GSK3B | 0.28678183 |
| 113 | RPS6KB1 | 0.25993435 |
| 114 | MAP2K1 | 0.25582558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.66302614 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.57781571 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.81510393 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.77769968 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.69450484 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.67272987 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.63321552 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61309591 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.50933180 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45123370 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.35279097 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21965300 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.16353849 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.09233519 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.93032813 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92492575 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79036109 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.76803685 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.75294312 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73021320 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70285092 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64599076 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64420799 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.63552903 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58471446 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57546045 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48549877 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42682825 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.35864782 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34008007 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32728756 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22535112 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22492936 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21845398 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.21717211 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18244188 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15401342 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12795561 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07446170 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06833545 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.06618195 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.05918450 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05467866 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01548321 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99377889 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.99042639 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97038367 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95229809 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90734129 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89404204 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88236667 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87934424 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84560698 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80438802 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80348269 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73482075 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73407789 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73321627 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70668287 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70532830 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64779395 |
| 62 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63161375 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62109073 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61410217 |
| 65 | Alcoholism_Homo sapiens_hsa05034 | 0.58921972 |
| 66 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58222092 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56877001 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56862454 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56734020 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56360348 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53932763 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53459097 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53280101 |
| 74 | * Endocytosis_Homo sapiens_hsa04144 | 0.52872946 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49828714 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49050301 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48427616 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47732470 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47248581 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45309439 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45163506 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.44465605 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43653567 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42152722 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41210343 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40819196 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40504100 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39845468 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.39405534 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38519070 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37941743 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37811370 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37775979 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.36575538 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36172808 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35120243 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33586238 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32720707 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32549683 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32102947 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31051544 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30906825 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29548952 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27904479 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27327816 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25640903 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.25448110 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25094076 |
| 109 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.22952337 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22320944 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19220766 |

